SCHEMBL6078671

SCHEMBL6078671

C#CCCOCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672370 0.85
SCHEMBL21071157 0.81
SCHEMBL19428353 0.81 TSHR (0.41)
SCHEMBL6860635 0.80
SCHEMBL23783686 0.79 ALDH1A1 (0.35)
SCHEMBL10707428 0.79
SCHEMBL7132326 0.76
SCHEMBL19432257 0.76 CHRNA7 (0.31)
SCHEMBL1727261 0.76 ALDH1A1 (0.37)
SCHEMBL22796362 0.75 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7041688-B2 E. g., 2',3',4',5,5',6,7,8,9,10-decahydro-2-(2-pyrid-3-yl-ethanediylidene-),5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-1,2,5-thiadiazole-1',1'-dioxide; inhibitors of gamma-secretase to modulate the processing of amyloid precursor protein (APP) MERCK SHARP & DOHME LT.D. (GB) 2006-05-09 US disclosed
US-20050215602-A1 Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease MERCK SHARP & DOHME LTD. (GB) 2005-09-29 US disclosed